Taiwan
· Delayed Price · Currency is TWD BIONET Statistics
Total Valuation
BIONET has a market cap or net worth of TWD 4.87 billion. The enterprise value is 4.58 billion.
| Market Cap | 4.87B |
| Enterprise Value | 4.58B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
BIONET has 47.29 million shares outstanding. The number of shares has increased by 0.55% in one year.
| Shares Outstanding | 47.29M |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | -0.31% |
| Owned by Insiders (%) | 6.80% |
| Owned by Institutions (%) | 0.52% |
| Float | 42.95M |
Valuation Ratios
The trailing PE ratio is 77.92.
| PE Ratio | 77.92 |
| Forward PE | n/a |
| PS Ratio | 4.18 |
| PB Ratio | 4.12 |
| P/FCF Ratio | 59.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.65, with an EV/FCF ratio of 56.30.
| EV / Earnings | 72.94 |
| EV / Sales | 3.93 |
| EV / EBITDA | 50.65 |
| EV / EBIT | 80.24 |
| EV / FCF | 56.30 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 4.87.
| Current Ratio | 4.02 |
| Quick Ratio | 3.77 |
| Debt / Equity | 4.87 |
| Debt / EBITDA | 1.10 |
| Debt / FCF | 1.23 |
| Interest Coverage | 80.79 |
Financial Efficiency
Return on equity (ROE) is 3.86% and return on invested capital (ROIC) is 2.03%.
| Return on Equity (ROE) | 3.86% |
| Return on Assets (ROA) | 1.50% |
| Return on Capital (ROIC) | 2.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.49 |
| Inventory Turnover | 8.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.44% in the last 52 weeks. The beta is 0.74, so BIONET's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +61.44% |
| 50-Day Moving Average | 121.00 |
| 200-Day Moving Average | 80.36 |
| Relative Strength Index (RSI) | 34.95 |
| Average Volume (20 Days) | 940,566 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIONET had revenue of TWD 1.16 billion and earned 62.74 million in profits. Earnings per share was 1.32.
| Revenue | 1.16B |
| Gross Profit | 639.75M |
| Operating Income | 57.04M |
| Pretax Income | 87.76M |
| Net Income | 62.74M |
| EBITDA | 81.36M |
| EBIT | 57.04M |
| Earnings Per Share (EPS) | 1.32 |
Balance Sheet
The company has 1.26 billion in cash and 99.69 million in debt, giving a net cash position of 1.16 billion or 24.50 per share.
| Cash & Cash Equivalents | 1.26B |
| Total Debt | 99.69M |
| Net Cash | 1.16B |
| Net Cash Per Share | 24.50 |
| Equity (Book Value) | 2.05B |
| Book Value Per Share | 25.03 |
| Working Capital | 1.27B |
Cash Flow
In the last 12 months, operating cash flow was 145.43 million and capital expenditures -64.15 million, giving a free cash flow of 81.29 million.
| Operating Cash Flow | 145.43M |
| Capital Expenditures | -64.15M |
| Free Cash Flow | 81.29M |
| FCF Per Share | 1.72 |
Margins
Gross margin is 55.01%, with operating and profit margins of 4.90% and 5.39%.
| Gross Margin | 55.01% |
| Operating Margin | 4.90% |
| Pretax Margin | 7.55% |
| Profit Margin | 5.39% |
| EBITDA Margin | 7.00% |
| EBIT Margin | 4.90% |
| FCF Margin | 6.99% |
Dividends & Yields
This stock pays an annual dividend of 0.71, which amounts to a dividend yield of 0.67%.
| Dividend Per Share | 0.71 |
| Dividend Yield | 0.67% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 52.00% |
| Buyback Yield | -0.55% |
| Shareholder Yield | 0.12% |
| Earnings Yield | 1.28% |
| FCF Yield | 1.67% |
Stock Splits
The last stock split was on September 23, 2010. It was a forward split with a ratio of 1.020894072.
| Last Split Date | Sep 23, 2010 |
| Split Type | Forward |
| Split Ratio | 1.020894072 |